PMID- 23105236
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20121030
LR  - 20240505
IS  - 0970-1915 (Print)
IS  - 0974-0422 (Electronic)
IS  - 0970-1915 (Linking)
VI  - 15
IP  - 1
DP  - 2000 Aug
TI  - Preliminary study on circulating serum levels of tumor necrosis factor-Alpha in 
      patients of tuberculosis.
PG  - 40-3
LID - 10.1007/BF02873546 [doi]
AB  - Tumor necrosis factor-alpha (TNF-alpha) has been implicated in the pathogenesis of 
      several non-infectious and infectious diseases including tuberculosis. In a 
      prospective longitudinal study, TNF-alpha level in blood was estimated by sandwich 
      ELISA using anti human TNF-alpha antibody, in 22 patients with active 
      pleuro-pulmonary and lymphnode tuberculosis before and after chemotherapy and 8 
      healthy controls. Six patients and six controls had detectable levels (> 5 pg/ml) 
      of TNF-alpha in blood. The mean TNF-alpha levels in controls and cases before and after 
      treatment were 182.4pg/ml, 896.7 pg/ml and 678.7pg/ml pg/ml respectively. Though 
      not statistically significant, there was a trend towards younger age, shorter 
      duration of symptoms, presence of fever and anorexia, and high ESR, in patient 
      with high serum TNF-alpha levels.
FAU - Gupta, R
AU  - Gupta R
AD  - Department of Medicine, All India Institute of Medical Sciences, 110029 New 
      Delhi.
FAU - Prasad, H K
AU  - Prasad HK
FAU - Nagarkar, K M
AU  - Nagarkar KM
FAU - Dey, A B
AU  - Dey AB
LA  - eng
PT  - Journal Article
PL  - India
TA  - Indian J Clin Biochem
JT  - Indian journal of clinical biochemistry : IJCB
JID - 8708303
PMC - PMC3453539
OTO - NOTNLM
OT  - Tumor necrosis factor
OT  - cytokines
OT  - tuberculosis
EDAT- 2000/08/01 00:00
MHDA- 2000/08/01 00:01
PMCR- 2001/08/01
CRDT- 2012/10/30 06:00
PHST- 2012/10/30 06:00 [entrez]
PHST- 2000/08/01 00:00 [pubmed]
PHST- 2000/08/01 00:01 [medline]
PHST- 2001/08/01 00:00 [pmc-release]
AID - BF02873546 [pii]
AID - 10.1007/BF02873546 [doi]
PST - ppublish
SO  - Indian J Clin Biochem. 2000 Aug;15(1):40-3. doi: 10.1007/BF02873546.